Like most chronic liver diseases, in NAFLD there is a long period during which an individual patient remains essentially asymptomatic. In asymptomatic individuals, the diagnosis is often made when a ...

Fatty liver disease, encompassing metabolic-associated fatty liver disease (MAFLD) and alcohol-associated liver disease (ALD), is now a significant global health issue. MAFLD is closely linked to ...

The use of Agile scores based on vibration-controlled transient elastography (VCTE) accurately predicted liver-related events in patients with metabolic dysfunction-associated steatotic liver disease ...

Liver tests should be obtained in all patients with suspected DILI. Calculating the ratio of the alanine aminotransferase (ALT) value/ALT upper limit of normal (ULN) divided by the alkaline ...

Fifty percent of T2DM patients also have NAFLD, confirmed via ultrasound, with elevated liver enzymes and altered lipid profiles. NAFLD and T2DM are key components of metabolic syndrome, sharing risk ...

Doctors can diagnose fatty liver disease, now called metabolic dysfunction-associated steatotic liver disease (MASLD), using blood tests that measure serum liver enzyme levels. Elevated enzyme levels ...

Researchers in Sweden and Finland have created the CORE model, a simple blood test that predicts liver disease risk with striking accuracy. Unlike current methods, it works for the general population ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), formally called nonalcoholic fatty liver disease (NAFLD), is a chronic condition that can lead to liver inflammation, damage, and ...